Panagora Asset Management’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $367K | Buy |
25,455
+2,474
| +11% | +$35.7K | ﹤0.01% | 881 |
|
|
2025
Q1 | $159K | Buy |
22,981
+11,157
| +94% | +$77K | ﹤0.01% | 1062 |
|
|
2024
Q4 | $62.7K | Buy |
+11,824
| New | +$62.7K | ﹤0.01% | 1121 |
|
|
2021
Q3 | – | Sell |
-863
| Closed | -$9K | – | 2420 |
|
|
2021
Q2 | $9K | Sell |
863
-145
| -14% | -$1.51K | ﹤0.01% | 2313 |
|
|
2021
Q1 | $9K | Hold |
1,008
| – | – | ﹤0.01% | 2454 |
|
|
2020
Q4 | $5K | Buy |
+1,008
| New | +$5K | ﹤0.01% | 2485 |
|
|
2017
Q3 | – | Sell |
-1,132
| Closed | -$4K | – | 2516 |
|
|
2017
Q2 | $4K | Buy |
+1,132
| New | +$4K | ﹤0.01% | 2531 |
|